Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2001-08-22 to 2001-09-05
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1200 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
92/69/EEC
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: Japan 59 NohSan Notification No. 4200, Acute Dermal Toxicity Study
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(2-oxoimidazolidin-1-yl)ethyl methacrylate
EC Number:
289-214-5
EC Name:
2-(2-oxoimidazolidin-1-yl)ethyl methacrylate
Cas Number:
86261-90-7
Molecular formula:
C9H14N2O3
IUPAC Name:
2-(2-oxoimidazolidin-1-yl)ethyl methacrylate
Test material form:
other: liquid

Test animals

Species:
rat
Strain:
other: Crl CD BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories, Raleigh, NC.
- Age at study initiation: Females were approximately 9 weeks old and males were 8 weeks old.
- Weight at study initiation: The body weights ranged from 258 to 275 g for males and from 203 to 241 for females.
- Fasting period before study:
- Housing: The animals were individually housed in suspended stainless steel cages (18x34~20c m) with wire mesh fronts and bottoms. Cages were suspended above absorbent-paper pan liners which were changed 3 times a week.
- Diet: Throughout the test period, all rats had free access to PMI Certified Rodent Diet 5002(C) (Purina Mills Inc., Richmond, IN).
- Water: Throughout the test period, all rats had free access to water (via automatic watering) purified by reverse osmosis.
- Acclimation period: approximately one week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-23
- Humidity (%): 46-58
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
occlusive
Vehicle:
water
Details on dermal exposure:
TEST SITE
- Area of exposure: entire trunk between flank and shoulders; intact skin
- % coverage: approx. 6*6 cm (10% of the body surface area (target))
- Type of wrap if used: Polyethylene sheet covered with Elastoplast elastic bandages and secured in place with adhesive tape.


REMOVAL OF TEST SUBSTANCE
- Washing: After the 24-hr exposure, the application sites were wiped with paper towels saturated with tap water and blotted dry with paper towels.
Duration of exposure:
24 h
Doses:
5000 mg/kg bw. The dose was calculated on an "as is" basis; no adjustment was made for percent active ingredient.
No. of animals per sex per dose:
5
Control animals:
other: Historical data were used for weight controls.
Details on study design:
All animals were observed for signs of ill health, or reaction to treatment at approximately 1, 2 and 4 hrs after dosing and once daily thereafter for 14 days. Body weights were recorded on day 0 (prior to dosing) and on days 7 and 14. Surviving rats were euthanized on day 14 and necropsied. Necropsy consisted of a gross examination of organs in situ.
Statistics:
not required

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
- Time of death: No mortality was observed.
- Number of deaths at each dose: No mortality was observed.
Clinical signs:
other: Scant feces was observed in 2 females on a single day during the observation period. Periodically during the study, the fur surrounding the eyes and muzzle of several animals was observed to be red stained; these effects were judged to be caused by the oc
Gross pathology:
No gross changes.
Other findings:
LOCAL FINDINGS
Signs of skin irritation including edema, erythema and desiccation was observed beginning day 1 of the observation period and continuing through day 11.

Applicant's summary and conclusion